Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rozerem in REM Sleep Behavior Disorder
NCT01401413Phase 4Completed
- Sponsor
- Sleep Medicine Centers of WNY
- Start
- Jan 2008
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ramelteon in REM sleep behavior disorder (RBD), sponsored by Sleep Medicine Centers of WNY. Started Jan 2008; status: completed.
02
Drugs
ramelteon
03
Conditions
REM sleep behavior disorder (RBD)
Beyond the preview
Go deeper on NCT01401413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01401413.